Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer Thérèse Dix-PeekBoitumelo P. PhakathiRaquel A. B. Duarte Preclinical study Open access 03 March 2023 Pages: 1 - 12
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer Alessio FiascarelliGiuseppe MerlinoMonica Binaschi Preclinical study Open access 13 March 2023 Pages: 13 - 23
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants Xuejing LiuYanjie WangYuntao Xie Preclinical study 17 March 2023 Pages: 25 - 33
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study Ailsa J. OswaldStefan N. SymeonidesDavid A. Cameron Clinical trial Open access 02 March 2023 Pages: 35 - 46
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study Jui-Hung TsaiChung-Liang LiYao-Lung Kuo Clinical trial 04 March 2023 Pages: 47 - 55
A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer Takeshi MurataMasayuki YoshidaAkihiko Suto Clinical trial Open access 04 March 2023 Pages: 57 - 66
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study Hanfang JiangHuiping LiHuan Wang Clinical trial Open access 06 March 2023 Pages: 67 - 79
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study Annemiek K. E. van HemertJosefien P. van OlmenFrederieke H. van Duijnhoven Clinical trial 09 March 2023 Pages: 81 - 89
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer Caitlin TaylorJane MeiselRuth O’Regan Clinical trial Open access 10 March 2023 Pages: 91 - 98
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases S. Chew MinminA. BacottiA. D. Seidman Clinical trial 17 March 2023 Pages: 99 - 107
The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors Justin C. BrownKathleen SturgeonKathryn H. Schmitz Clinical trial 18 March 2023 Pages: 109 - 117
Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy? Anita MamtaniDaniel D. SjobergMonica Morrow Epidemiology 07 March 2023 Pages: 119 - 126
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil Patricia MazzonettoFernanda MilaneziIlana Zalcberg Epidemiology 07 March 2023 Pages: 127 - 136
mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women’s circle of health study Mmadili N. IlozumbaLusine YaghjyanTing-Yuan David Cheng Epidemiology 08 March 2023 Pages: 137 - 146
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay Amber N. HursonAlina M. HamiltonMelissa A. Troester Epidemiology Open access 09 March 2023 Pages: 147 - 154
Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration Kate E. DibbleRichard N. BaumgartnerAvonne E. Connor Epidemiology 09 March 2023 Pages: 155 - 172
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score Florian EbnerJessica SalmenManfred Wischnewsky Epidemiology Open access 14 March 2023 Pages: 173 - 184
History of infertility and risk of breast cancer: a prospective cohort study Leslie V. FarlandSiwen WangStacey A. Missmer Epidemiology 16 March 2023 Pages: 185 - 193
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study Oliver William ScottSandar TinTinJ. Mark Elwood Epidemiology Open access 17 March 2023 Pages: 195 - 206
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells Kennedy W. MwangiMoses K. KamitaFrancis W. Makokha Original Laboratory Investigation 08 March 2023 Pages: 207 - 214
